Vanderbilt's Emerging Infections Program (EIP) recently received the Toby Merlin Award for Excellence in Emergency Response, presented by the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry.

Vanderbilt's Stacie Dusetzina, PhD, and several colleagues were able to reflect recently on the South Lawn of the White House about how their contributions through research and data informed the provisions in the Inflation Reduction Act that will save older Americans on Medicare tens of thousands of dollars in out-of-pocket costs each year.

A panel of experts on opioid use disorder (OUD) recently discussed the importance of building recovery ecosystems or networks of resources to respond to the opioid epidemic.

Vanderbilt research finds that hospitals' 30-day readmission rates were lower if they had a larger supply of primary care physicians, nursing homes or palliative care services nearby.

Vanderbilt researchers found that both gender dysphoria diagnoses and use of gender therapies have increased substantially between 2013 and 2019.

Renowned physician-epidemiologist Muktar Aliyu, MBBS, MPH, DrPH, who is the associate director for Research with the Vanderbilt Institute for Global Health (VIGH), has been named the new director of the institute, beginning July 1.

In a new study led by Vanderbilt University Medical Center researchers, women who filled two or more prescriptions for opioids after childbirth faced a 46% greater risk of death than women who did not.